The PBMC levels of laminin receptor 1 (LAMR1) mRNA are downregulated in early RA patients and might be an independent predictor of poor anti-TNF-α therapy response; in addition, these levels are associated with increased disease activity scores (84). This evidence concerns the gene TNF and rheumatoid arthritis.